ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 99 filers reported holding ARATANA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $131,000 | -89.3% | 21,300 | -83.7% | 0.01% | -80.0% |
| Q3 2016 | $1,226,000 | +93.1% | 131,000 | +74.7% | 0.02% | +4.2% |
| Q3 2015 | $635,000 | -83.3% | 75,000 | -70.2% | 0.02% | -75.5% |
| Q2 2015 | $3,809,000 | -5.3% | 251,900 | +0.2% | 0.10% | -12.5% |
| Q1 2015 | $4,023,000 | -9.7% | 251,300 | +0.5% | 0.11% | -29.6% |
| Q4 2014 | $4,455,000 | +136.6% | 250,000 | +33.3% | 0.16% | +123.9% |
| Q3 2014 | $1,883,000 | -30.7% | 187,500 | +7.7% | 0.07% | -42.7% |
| Q2 2014 | $2,718,000 | -2.4% | 174,088 | +16.1% | 0.12% | -14.5% |
| Q1 2014 | $2,784,000 | +46.9% | 150,000 | +33.3% | 0.14% | +11.5% |
| Q4 2013 | $1,895,000 | +0.9% | 112,500 | -2.2% | 0.13% | -23.5% |
| Q3 2013 | $1,879,000 | +42.0% | 115,000 | -34.3% | 0.17% | +25.0% |
| Q2 2013 | $1,323,000 | – | 175,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |